An underground economy for unlicensed slimming drugs is being driven by social media fitness personalities and sellers on messaging platforms, based on recent findings.
Experimental Drug Gaining Popularity Via Social Media
The experimental drug, which is still in clinical trials, is being advertised by online personalities for its supposed weight-reducing properties. Followers are urged to contact these profiles directly for source information, while also obtaining promotional offers.
Active Commerce on Messaging Platforms
Separately, a robust market exists on Telegram, where groups with thousands of participants share “before and after” images, administration instructions and claims of rapid UK delivery. Sellers promote the substance there before redirecting customers to other platforms for purchases.
Understanding The Experimental Drug
This medication is an investigational injectable developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could assist individuals lose up to 25% of their total weight. Nicknamed the “triple G”, the substance is being hailed online as the next Ozempic.
Medical Experts Voice Concerns
Nevertheless, doctors and chemists have warned that the distribution of what remains an unapproved medication in the United Kingdom is worrisome and could lead to individuals injecting substances of uncertain source.
Several professionals stated the demand for retatrutide could be connected to the rising cost of approved weight loss products such as Mounjaro.
Legal Status and Enforcement
Marketing the unapproved drug on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed medication that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.
Some influencers attempt to circumvent the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and distribution can still violate medicines, advertising, and consumer laws, potentially leading to penalties, prosecution or imprisonment.
Platform Reaction and Material Elimination
According to TikTok, the service has removed problematic content and banned associated keywords and search suggestions. The organization said it was dedicated to maintaining the service secure and investing in strengthening compliance measures.
Online Marketplace Operations
Research also found communities with up to nine thousand members selling retatrutide using Telegram's integrated search feature, which operates like a online catalog. Entering “retatrutide” immediately displays groups with thousands of members, populated with images of slimming results, glowing reviews and step-by-step guides for mixing or injecting at residence.
After moments of joining one group, a seller shared WhatsApp details, where the majority of transactions take place. The seller sent an instruction manual and guaranteed delivery within 48 hours. When asked whether the product was genuine, one seller said: “You can’t be sure.” Another shared a image of a alleged testing documentation. Not one inquired about body mass, health issues or past usage.
Item Details and Costs
Within these communities, messages display black plastic parcels with postal service stickers, claiming to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”
Customers can select between powder vials, mixed at home with purified liquid, or pre-filled injectors usually sold at 160 pounds for 20mg. When questioned how much time a pen should last, sellers give conflicting answers ranging from a several days to “depends on your body”.
Platform Oversight and Safety Actions
A spokesperson for the messaging service said it actively monitored dangerous material on its service including content that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Cautions
“People are injecting materials they cannot confirm. Even if the research behind this drug is valid, these digital versions may not include what they claim,” stated a pharmacy expert, the director of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor linked the increase in demand to recent price rises for approved slimming drugs such as Mounjaro. “With prices rising, individuals are turning to social media. But counterfeit treatments are extremely risky. You cannot know what’s contained or whether the conditions they were produced in was clean,” she said.
Her staff has previously encountered individuals injured by personal administration from unverified suppliers. “We understand the frustration, but buying from messaging apps or WhatsApp is gambling with your health,” stated the doctor. “These materials could be impure or incorrectly dosed.”
Manufacturer Position
A representative from Eli Lilly stated retatrutide was in third stage research studies and had not been reviewed or authorized by any government authority anywhere in the world. “Consequently at this point no one can sell [it] for personal consumption,” they said, adding that any item “misleadingly claiming itself as a company investigational product not yet approved … may subject users to potentially serious health risks”.
